<DOC>
	<DOCNO>NCT01902615</DOCNO>
	<brief_summary>This multicenter , retrospective , observational study evaluate therapeutic effectiveness strategy induction Fuzeon ( enfuvirtide ) within optimize regimen antiretroviral drug patient HIV-1 infection routine clinical practice .</brief_summary>
	<brief_title>An Observational Study Induction Therapy With Fuzeon ( Enfuvirtide ) Combination With Antiretroviral Drugs Patients With HIV-1 Infection</brief_title>
	<detailed_description />
	<mesh_term>Infection</mesh_term>
	<mesh_term>HIV Infections</mesh_term>
	<mesh_term>Enfuvirtide</mesh_term>
	<criteria>Adult patient , &gt; /= 18 year age HIV1+ infection Patients viral load &gt; 50 copies/ml receive induction treatment Fuzeon combination antiretroviral treatment Na√Øve Fuzeon initiation induction treatment Antiretroviral treatment least 12 month duration Patients receive Fuzeon treatment</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2016</verification_date>
</DOC>